---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-098032"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2024-08-16T23:59:59+00:00"
generated_at: "2026-05-31T08:51:09.846716+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cue Biopharma receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received Nasdaq notice on August 15, 2024 for failure to meet minimum bid price of $1.00 for 30 consecutive business days.
- Has 180 calendar days (until Feb 11, 2025) to regain compliance by having bid price ≥$1.00 for 10 consecutive business days.
- If not compliant, may qualify for another 180-day period, subject to meeting other listing standards.
- Company will evaluate options including potential reverse stock split to cure deficiency.
- No assurance of regaining compliance; stock remains listed pending cure or potential delisting appeal.

## SEC filing metadata
- accession: 0000950170-24-098032
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2024-08-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000095017024098032/0000950170-24-098032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000095017024098032/cue-20240815.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-098032
- JSON: https://secwatch.observer/filing/0000950170-24-098032.json
- Plain text: https://secwatch.observer/filing/0000950170-24-098032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.